Nabriva Therapeutics Cash from Investing (TTM)

Nabriva Therapeutics PLC (NBRV)

1.47 -0.03 (-1.73%) USD | NASDAQ | Jun 06, 11:31

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2023	-0.23M
December 31, 2022	-0.263M
September 30, 2022	-0.268M
June 30, 2022	-0.164M
March 31, 2022	0.003M
December 31, 2021	-0.081M
September 30, 2021	-0.086M
June 30, 2021	-0.095M
March 31, 2021	-0.374M
December 31, 2020	-0.274M
September 30, 2020	-0.057M
June 30, 2020	0.14M
March 31, 2020	0.353M
December 31, 2019	0.331M
September 30, 2019	-0.098M
June 30, 2019	-4.378M
March 31, 2019	-4.486M

Date	Value
December 31, 2018	-4.604M
September 30, 2018	-3.987M
June 30, 2018	31.70M
March 31, 2018	39.61M
December 31, 2017	49.75M
September 30, 2017	47.18M
June 30, 2017	25.42M
March 31, 2017	30.40M
December 31, 2016	23.35M
September 30, 2016	-51.03M
June 30, 2016	-60.94M
March 31, 2016	-73.73M
December 31, 2015	-76.70M
September 30, 2015	-0.21M
June 30, 2015	-0.1427M
March 31, 2015	-0.1201M
December 31, 2014	-0.087M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-4.604M

Minimum

Dec 2018

31.70M

Maximum

Jun 2018

0.6541M

Average

-0.131M

Median

Cash from Investing (TTM) Benchmarks